MX9300560A - Formulacion farmaceutica liposomal de fotosensibilizadores de porfirina. - Google Patents

Formulacion farmaceutica liposomal de fotosensibilizadores de porfirina.

Info

Publication number
MX9300560A
MX9300560A MX9300560A MX9300560A MX9300560A MX 9300560 A MX9300560 A MX 9300560A MX 9300560 A MX9300560 A MX 9300560A MX 9300560 A MX9300560 A MX 9300560A MX 9300560 A MX9300560 A MX 9300560A
Authority
MX
Mexico
Prior art keywords
photosensitizers
porphyrine
pharmaceutical formulation
liposomal pharmaceutical
liposomal
Prior art date
Application number
MX9300560A
Other languages
English (en)
Inventor
Narendra Raghunathji Desai
Bushra J Agha
Kalidas Madhavrao Kale
James R Lawter
Original Assignee
Quadra Logic Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quadra Logic Tech Inc filed Critical Quadra Logic Tech Inc
Publication of MX9300560A publication Critical patent/MX9300560A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Radiation-Therapy Devices (AREA)

Abstract

La presente invención se relaciona con formulaciones farmacéuticas liposomales que incorporan fotosensibilizadores de porfirina útiles para la terapia fotodinámica o diagnóstico de la células malignas. Las formulaciones liposomales comprenden un fotosensibilizador de porfirina, particularmente las hidromonobenzoporfirinas (BPD) que tienen una absorción máxima de luz en el intervalo de 670-780 nanómetros, un disacárido o polisacárido y uno o más fosfolípidos.
MX9300560A 1992-02-05 1993-02-02 Formulacion farmaceutica liposomal de fotosensibilizadores de porfirina. MX9300560A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US83254292A 1992-02-05 1992-02-05

Publications (1)

Publication Number Publication Date
MX9300560A true MX9300560A (es) 1993-09-01

Family

ID=25261954

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9300560A MX9300560A (es) 1992-02-05 1993-02-02 Formulacion farmaceutica liposomal de fotosensibilizadores de porfirina.

Country Status (11)

Country Link
US (1) US6074666A (es)
EP (1) EP0569113B1 (es)
JP (1) JP3020372B2 (es)
KR (1) KR970007303B1 (es)
AT (1) ATE151984T1 (es)
CA (1) CA2087902C (es)
DE (1) DE69310014T2 (es)
DK (1) DK0569113T3 (es)
ES (1) ES2100452T3 (es)
GR (1) GR3023906T3 (es)
MX (1) MX9300560A (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6890555B1 (en) * 1992-02-05 2005-05-10 Qlt, Inc. Liposome compositions of porphyrin photosensitizers
AR002009A1 (es) * 1994-12-22 1998-01-07 Astra Ab Composicion farmaceutica, procedimiento para la manufactura de un polvo de proliposoma como el utilizado en dicha composicion, procedimiento para lamanufactura de dicha composicion, uso de dicha composicion farmaceutica en la manufactura de un medicamento y dispositivo inhalador de polvo seco.
US5707608A (en) * 1995-08-02 1998-01-13 Qlt Phototherapeutics, Inc. Methods of making liposomes containing hydro-monobenzoporphyrin photosensitizer
JP2001511128A (ja) * 1997-01-28 2001-08-07 ファルマシア・アンド・アップジョン・カンパニー 水不溶性ポルフィリンの脂質錯体の凍結乾燥物
WO1999013916A2 (en) * 1997-09-18 1999-03-25 Nycomed Imaging As Methods and compositions for medical imaging
EP0911023A1 (en) * 1998-03-20 1999-04-28 Mario Luca Russo Pharmaceutical or cosmetic compositions containing photosensitizing substances
DE19852245A1 (de) * 1998-11-12 2000-05-18 Asat Ag Applied Science & Tech 5-Aminolävulinsäure-Nanoemulsion
ATE286741T1 (de) * 1999-01-27 2005-01-15 Telik Inc Glutathioneanaloge enthaltende therapeutische zusammensetzungen
US6608050B2 (en) 1999-07-20 2003-08-19 Pharmacia & Upjohn Company Lyophilizate of lipid complex of water insoluble porphyrins
CZ20023174A3 (cs) 2000-03-24 2003-01-15 Novartis Ag Farmaceutické prostředky obsahující antiangiogenní léčivo a fotosenzitivní činidlo
CA2408332C (en) * 2000-05-08 2011-02-15 The University Of British Columbia Supports for photosensitizer formulations
US6984395B2 (en) * 2001-04-11 2006-01-10 Qlt, Inc. Drug delivery system for hydrophobic drugs
CA2466103C (en) * 2001-11-02 2010-06-15 The Governors Of The University Of Alberta Micelle compositions containing pegylated phospholipids and a photosensitizer
EP1594875A4 (en) 2003-01-16 2007-07-11 Technomart Co Ltd porphyrin derivatives
US20040220167A1 (en) * 2003-05-02 2004-11-04 Nasrollah Samiy Methods of treating neuralgic pain
JP4741205B2 (ja) * 2003-07-07 2011-08-03 真 湯浅 金属ポルフィリン錯体包埋リポソーム、その製造方法およびこれを利用する医薬
US8986731B2 (en) 2003-08-26 2015-03-24 Biolitec Pharma Marketing Ltd Pegylated liposomal formulations of hydrophobic photosensitizers for photodynamic therapy
US20050048109A1 (en) * 2003-08-26 2005-03-03 Ceramoptec Industries, Inc. Non-polar photosensitizer formulations for photodynamic therapy
US8709449B2 (en) * 2004-02-12 2014-04-29 Biolitec Pharma Marketing Ltd Methods and compositions for improving photodynamic therapy through administration of lipids
US20070031482A1 (en) * 2005-08-02 2007-02-08 Ceramoptec Industries, Ind. PDT treatment method for cellulites and cosmetic use
CA2631243A1 (en) * 2005-12-08 2007-06-14 Wyeth Liposomal compositions
US7465312B2 (en) 2006-05-02 2008-12-16 Green Medical, Inc. Systems and methods for treating superficial venous malformations like spider veins
WO2007130465A2 (en) * 2006-05-02 2007-11-15 Green Medical, Inc. Systems and methods for treating superficial venous malformations like spider veins
WO2007136633A2 (en) * 2006-05-18 2007-11-29 Ceramoptec Industries, Inc. Gel-formulations of hydrophobic photosensitizers for mucosal applications
WO2008088037A1 (ja) * 2007-01-18 2008-07-24 National University Corporation Chiba University 微粒子製剤
WO2009065065A1 (en) * 2007-11-15 2009-05-22 Ceramoptec Industries, Inc. Pegylated liposomal formulations for photodynamic treatment of inflammatory diseases
US9040079B2 (en) * 2007-11-19 2015-05-26 Biolitec Pharma Marketing Ltd Pegylated compounds for age-related macular degeneration
US20100310660A1 (en) * 2009-06-08 2010-12-09 Taipei Medical University Dry powder microparticles for pulmonary delivery
US9211214B2 (en) 2012-03-21 2015-12-15 Valeant Pharmaceuticals International, Inc Photodynamic therapy laser
KR102630617B1 (ko) * 2016-06-24 2024-01-29 (주) 에이치엔에이파마켐 페오포르비드 a 및 폴리에틸렌글리콜의 지질 유도체의 결합체를 함유하는 항균 리포좀 조성물
WO2019173884A1 (pt) * 2018-03-15 2019-09-19 Bebeachibuli Romeo Normalizador biológico, processo de obtenção de normalizador biológico e produtos obtidos com o normalizador biológico

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4649151A (en) * 1982-09-27 1987-03-10 Health Research, Inc. Drugs comprising porphyrins
JPS60188329A (ja) * 1984-03-07 1985-09-25 Ajinomoto Co Inc リポソ−ム封入物質移入促進剤
US4880635B1 (en) * 1984-08-08 1996-07-02 Liposome Company Dehydrated liposomes
US4776991A (en) * 1986-08-29 1988-10-11 The United States Of America As Represented By The Secretary Of The Navy Scaled-up production of liposome-encapsulated hemoglobin
US4920143A (en) * 1987-04-23 1990-04-24 University Of British Columbia Hydro-monobenzoporphyrin wavelength-specific cytotoxic agents
JPH0780887B2 (ja) * 1988-07-19 1995-08-30 ザ ユニバーシティ オブ ブリティッシュ コロンビア 波長特異的細胞毒性試薬
US4913907A (en) * 1988-08-15 1990-04-03 Cytopharm, Inc. Porphycene anti-cancer agents and treatment methods
US5010073A (en) * 1989-10-05 1991-04-23 The Rockefeller University Use of liposomes as carriers for metalloporphyrins
IL97681A (en) * 1990-04-03 1996-01-31 Ciba Geigy Ag Parenterally administrable liposome formulation comprising synthetic lipids
US5270053A (en) * 1990-04-03 1993-12-14 Ciba-Geigy Corp. Parenterally administerable liposome formulation comprising synthetic lipid
CA2047969A1 (en) * 1990-08-17 1992-02-18 Thomas D. Madden Benzoporphyrin vesicles
GB9111611D0 (en) * 1991-05-30 1991-07-24 Sandoz Ltd Liposomes

Also Published As

Publication number Publication date
ES2100452T3 (es) 1997-06-16
CA2087902C (en) 2006-10-17
GR3023906T3 (en) 1997-09-30
KR970007303B1 (ko) 1997-05-07
JP3020372B2 (ja) 2000-03-15
EP0569113A1 (en) 1993-11-10
ATE151984T1 (de) 1997-05-15
JPH06122628A (ja) 1994-05-06
DE69310014T2 (de) 1997-11-06
DK0569113T3 (da) 1997-05-20
EP0569113B1 (en) 1997-04-23
DE69310014D1 (de) 1997-05-28
US6074666A (en) 2000-06-13
CA2087902A1 (en) 1993-08-06

Similar Documents

Publication Publication Date Title
MX9300560A (es) Formulacion farmaceutica liposomal de fotosensibilizadores de porfirina.
Kübler Photodynamic therapy
ES2743446T3 (es) Dispositivos para proporcionar el cuidado de la piel mediante el uso de fototerapia
ATE92930T1 (de) Saponinkomplexe mit phospholipiden und sie enthaltende pharmazeutische und kosmetische zusammensetzungen.
ATE91903T1 (de) Pharmazeutische kombinationspraeparate und deren verwendung als antineoplastische arzneimittel.
Calzavara‐Pinton et al. Photodynamic therapy: update 2006 Part 2: Clinical results
DE69822496D1 (de) Lipidkomplex-lyophilisat von wasserunlöslichen porphyrinen
NO302173B1 (no) Pyrofeoforbindelser, preparater og konjugater inneholdende dem, samt deres anvendelse
TR199500832A2 (tr) Benzimidazol türevleri ve bunlarin medikal terapide kullanimi ve bunlari iceren farmasötik formülasyonlar.
MY116474A (en) Potentiation of temozolomide in human tumour cells
Wachter et al. Simultaneous two-photon excitation of photodynamic therapy agents
RU95106680A (ru) Бициклические ароматические соединения и содержащие их фармацевтические и косметические композиции
NO20002827D0 (no) Anvendelse av fosfolipidkomplekser av Vitis vinifera som antiaterosklerotiske midler
ES2063767T3 (es) Esteres aromaticos policiclicos de antibioticos macrolidicos y lincosamidicos, su procedimiento de preparacion y composiciones farmaceuticas y cosmeticas que los contienen.
EP2226318A3 (en) Dye-Azide compounds for dual photherapy
WO2003004466A3 (en) Dye-sulfenates for dual phototherapy
EP1269978A3 (de) Verwendung von Bis-Resorcinyltriazinderivaten in kosmetischen oder dermatologischen Zubereitungen
MX9300558A (es) Nueva sulfonilurea, procedimiento para su preparacion y formulado farmaceutico que la contiene.
Willis et al. Resistant psoriasis: Combined methoxsalen-anthralin therapy
DK0773782T3 (da) Terpenderivater (sarcodictyiner) anvendelse som antitumormidler
ATE5073T1 (de) 5-amino-tetrazol-derivate von retinsaeuren, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
AU2525488A (en) Use of metalloporphyrins to reverse the toxic effect of tumor therapy
ES2063056T3 (es) Esteres poliaromaticos de antibioticos macrolidicos y lincosamidicos, su procedimiento de preparacion y composiciones farmaceuticas y cosmeticas que los contienen.
DE69009765D1 (de) Kynurensäurederivate, deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
WO1999003509A3 (de) Pharmazeutische mittel enthaltend perfluoralkylgruppenhaltige trijodaromaten und ihre verwendung in der tumortherapie und interventionellen radiologie